News und Analysen
EQS-News: E.ON concludes fiscal year with strong earnings and record investments in the energy transition
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re plans dividend of €20 per share for 2024 and resolves share buy-back with volume of up to €2.0bn
Is Merck Stock a Buy?
It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates with
EQS-News: Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC
PUMA’s Sustainability Efforts for Climate, Water Security and Forests Receive ‘Leadership Level’ Scores From CDP
Sports company PUMA has received strongly improved scores for its sustainability efforts regarding water security and forests and maintained a top score for its climate policy in the latest ratings
PUMAs Nachhaltigkeitsinitiativen in den Bereichen Klima, Wassersicherheit und Wälder von CDP mit ‚Leadership Level‘-Noten ausgezeichnet
Das Sportunternehmen PUMA hat sich in der aktuellen Bewertung der internationalen Non-Profit-Organisation CDP in den Bereichen Wassersicherheit und Wälder erheblich verbessert und für seine
EQS-Adhoc: Airbus reports Full-Year (FY) 2024 results
Why Siemens Stock Crept Higher on Friday
German industrial conglomerate Siemens (OTC: SIEGY) was a somewhat under-the-radar winner on the stock exchange on Friday. The company's shares enjoyed a more than 1% bump in price, as investors
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Most companies don't survive for decades, much less pay regular dividends for that long. However, some rare corporations can pull it off. These are the kinds of stocks long-term investors will often
EQS-Adhoc: Deutsche Börse AG: Deutsche Börse AG resolves a share buyback program of €500 million in 2025
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
Better High-Yield Dividend Stock: Pfizer vs. Merck
Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical industry. At recent prices, you can buy shares of Merck (NYSE: MRK) that
Linde: Q4 Sales Flat, but Margins Widen
Linde (NASDAQ:LIN), a leading industrial gases company, revealed its fourth-quarter results on Feb. 6. While it exceeded bottom-line estimates by reporting earnings per share (EPS) of $3.97 against
EQS-News: Hannover Re increases premium volume in the renewals and achieves Group profit of EUR 2.3 billion for 2024
Merck (MRK) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q4 2024 Earnings CallFeb 04, 2025, 9:00 a.m. ET
Operator
Source Fool.com
Why Merck Stock Is Plummeting Today
Shares of Merck (NYSE: MRK) were trading lower on Tuesday. The company's stock had lost 10.1% as of 2 p.m. ET, but was down as much as 12.5% earlier in the day. The drop comes as the S&P 500 gained
EQS-News: Infineon has a slightly better start to the fiscal year than expected and raises its outlook for the year due to currency effects
EQS-News: Symrise achieves significant sales growth in 2024 with a strong increase in profitability
EQS-Adhoc: Airbus reports share buyback transactions 20-24 January 2025
Why This Beaten-Down Stock Is a Buy in 2025 and Beyond
Last year wasn't a good one for Merck (NYSE: MRK), one of the largest pharmaceutical companies in the world. The healthcare giant is dealing with the fast-approaching patent cliff for its most
EQS-News: Vonovia shareholders back domination and profit and loss transfer agreement with Deutsche Wohnen
EQS-Adhoc: BASF SE: BASF Group releases preliminary figures for full year 2024
EQS-News: PUMA accelerates growth throughout 2024 and initiates program to increase profitability
EQS-Adhoc: PUMA SE: PUMA announces preliminary results for the fourth quarter and the full year 2024
EQS-Adhoc: adidas finishes successful year with better-than-expected fourth quarter results